ArticleFrontiers in pharmacology2023
A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014-2022).
Cong-Cong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it